medigraphic.com
ISSN 0028-3851 (Print)

2018, Number 2

<< Back Next >>

Rev Neurol Neurocir Psiquiat 2018; 46 (2)

Obstructive sleep apnea/hypopnea syndrome, depression, and anxiety

Barrera MA

Language: Spanish
References: 48
Page: 48-51
PDF size: 200.29 Kb.


ABSTRACT

We review the relationship between the sleep apnea/hypopnea syndrome (OSAHS) and relevant depressive and anxious disorders. The prevalence of psychiatric disorders is high in patients with OSAHS. Of the psychiatric disorders, depression, anxiety and post-traumatic stress disorder in particular are often associated with OSAHS. Continuous positive airway pressure (CPAP) is the treatment of choice for patients with moderate and severe OSAHS. Many clinical trials have been done to evaluate the effectiveness of CPAP in these psychiatric disorders.


REFERENCES

  1. Watson HJ, Swan A, Nathan PR. Psychiatric diagnosis and quality of life: the additional burden of psychiatric comorbidity. Compr Psychiatry. 2011; 52 (3): 265-272.

  2. Medina-Mora ME, Borges G, Lara C, Benjet C, Lara C, Berglund P. Psychiatric disorders in Mexico: lifetime prevalence in a nationally representative sample. Br J Psychiatry. 2007; 190: 521-528.

  3. American Psychiatric Association. Diagnosis and statistical manual of mental disorder. American Psychiatric Association. 2013.

  4. Barrera-Medina A, Arana-Lechuga DY, Sánches-Escandón O, Velázquez-Moctezuma J. Update of sleep alterations in depression. Sleep Sci. 2014; 7 (3): 165-169.

  5. Winokur A. The relationship between sleep disturbances and psychiatric disorders. Psychiatr Clin N Am. 2015; 38 (4): 603-614.

  6. Andrews JG, Oei TP. The roles of depression and anxiety in the understanding and treatment of obstructive sleep apnea syndrome. Clin Psychol Rev. 2004; 24 (8): 1031-1049.

  7. Björnsdóttir E, Benediktsdóttir B, Pack A, Arnardottir ES, Kuna S, Gíslason T et al. The prevalence of depression among untreated obstructive sleep apnea patients using a standardized psychiatric interview. J Clin Sleep Med. 2016; 12 (1): 105-112.

  8. Lang C, Appleton SL, Vakulin A, McEvoy RD, Wittert G, Martin SA et al. Co-morbid OSA and insomnia increases depression prevalence and severity in men. Respirology. 2017; 22 (7): 1407-1415.

  9. Lanfranco F, Motta G, Minetto MA, Baldi M, Balbo M, Ghingo E et al. Neuroendocrine alterations in obese patients with sleep apnea syndrome. Int J Endocrinol. 2010; 2010 (474518): 1-11.

  10. Kaplan R. Obstructive sleep apnoea and depression. Diagnostic and treatment implications. Aust N Z J Psychiatry 1992; 26 (4): 586-591.

  11. Lipford MC, Ramar K, Liang YJ, Lin CW, Chao YT, Chiu CH et al. Serotonin as a possible biomarker in obstructive sleep apnea. Sleep Med Rev. 2016; 28 (4): 125-132.

  12. Jagannathan R, Seixas A, St-Jules D, Jagannathan L, Rogers A, Hu L et al. Systems biology genetic approach identifies serotonin pathway as possible target for obstructive sleep apnea: results from a literature search review. Sleep Disord. 2017; 2017: 6768323.

  13. Smith SS, Dingwall K, Jorgenson G, Douglas J. Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea. J Clin Sleep Med. 2006; 2 (2): 156-162.

  14. Brownell L, West P, Sweatmen P, Acres J, Kryger M. Protriptyline in obstructive sleep apnoea: a double blind trial. N Engl J Med. 1982; 307 (17): 1037-1042.

  15. Heck T, Zolezzi M. Obstructive sleep apnea: management considerations in psychiatric patients. Neuropsychiatr Dis Treat. 2015; 11: 2691-2698.

  16. White D. Pharmacologic approaches to the treatment of obstructive sleep apnea. Sleep Med Clin. 2016; 11 (2): 203-212.

  17. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest. 1991; 100 (2): 416-4121.

  18. Kraiczi H, Hedner J, Dahlöf P, Ejnell H, Carlson J. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep. 1999; 22 (1): 61-67.

  19. Smales ET, Edwards BA, Deyoung PN, McSharry DG, Wellman A, Velasquez A et al. Trazodone effects on obstructive sleep apnea and non-REM arousal threshold. Ann Am Thorac Soc. 2015; 12 (5): 758-764.

  20. Marshall NS, Yee BJ, Desai AV, Buchanan PR, Wong KK, Crompton R et al. Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep. 2008; 31 (6): 824-831.

  21. Harris M, Glozier N, Ratnavadivel R, Grunstein RR. Obstructive sleep apnea and depression. Sleep Med Rev. 2009; 13 (6): 437-444.

  22. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997; 82 (5): 1313-1316.

  23. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab. 2004; 89 (9): 4409-4413.

  24. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007; 21 (4): 374-383.

  25. El-Sherbini AM, Salah Bediwy A, El-Mitwalli A. Association between obstructive sleep apnea and the effect of continuous positive airway pressure treatment. Neuropsychiatr Dis Treat. 2011; 7 (1): 715-721.

  26. Eldahdouh SS, El-Habashy MM, Elbahy MS. Effect of CPAP on depressive symptoms in OSA. Egypt J Chest Dis Tuberculosis. 2014; 63 (2): 389-393.

  27. Dalmases M, Solé-Padullés C, Torres M, Embid C, Nuñez MD, Martínez-García MA et al. Effect of CPAP on cognition, brain function, and structure among elderly patients with OSA. Chest. 2015; 148 (5): 1214-1223.

  28. Lee IS, Bardwell W, Ancoli-Israel S, Loredo JS, Dimsdale JE. Effect of three weeks of continuous positive airway pressure treatment on mood in patients with obstructive sleep apnoea: a randomized placebo-controlled study. Sleep Med. 2012; 13 (2): 161-166.

  29. Saunamaki T, Jehkonen M. Depression and anxiety in obstructive sleep apnea syndrome: a review. Acta Neurol Scand. 2007; 116 (5): 277-288.

  30. Douglas N, Young A, Roebuck T, Ho S, Miller BR, Kee K et al. Prevalence of depression in patients referred with snoring and obstructive sleep apnoea. Intern Med J. 2013; 43 (6): 630-634.

  31. Shapiro AL, Culp S, Azulay-Chertok IR. OSA symptoms associated with and predictive of anxiety in middle-aged men: secondary analysis of NHANES data. Arch Psychiatr Nurs. 2014; 28 (3): 200-205.

  32. Letho MS, Sahlman J, Soini EJ, Gylling H, Vanninen E, Seppa J et al. The association between anxiety and the degree of illness in mild obstructive sleep apnoea. Clin Respir J. 2013; 7 (2): 197-203.

  33. Macey MP, Woo MA, Kumar R, Cross RL, Harper RM. Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients. PLoS One. 2010; 5 (4): e10211.

  34. Lai CH. Gray matter deficits in panic disorder: a pilot study of meta-analysis. J Clin Psychopharmacol. 2011; 31 (3): 287-293.

  35. Massana G, Serra-Grabulosa JM, Salgado-Pineda P, Gastó C, Junqué C, Massana J et al. Parahippocampal gray matter density in panic disorder: a voxel-based morphometric study. Am J Psychiatry. 2003; 160 (3): 566-568.

  36. Sobanski T, Wagner G, Peikert G, Gruhn U, Schluttig K, Sauer H et al. Temporal and right frontal lobe alterations in panic disorder: a quantitative volumetric and voxel-based morphometric MRI study. Psychol Med. 2010; 40 (11): 1879-1886.

  37. Gale SD, Hopkins RO. Effects of hypoxia on the brain: neuroimaging and neuropsychological findings following carbon monoxide poisoning and obstructive sleep apnea. J Int Neuropsychol Soc. 2004; 10 (1): 60-71.

  38. Zimmerman ME, Aloia MS. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med. 2006; 2 (4): 461-471.

  39. Macey PM, Henderson LA, Macey KE, Alger JR, Frysinger RC, Woo MA et al. Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med. 2002; 166 (10): 1382-1387.

  40. Asami T, Hayano F, Nakamura M, Yamasue H, Uehara K, Otsuka T et al. Anterior cingulate cortex volume reduction in patients with panic disorder. Psychiatry Clin Neurosci. 2008; 62 (3): 322-330.

  41. Kumar R, Macey PM, Cross RL, Woo MA, Yan-Go FL, Harper RM. Neural alterations associated with anxiety symptoms in obstructive sleep apnea syndrome. Depress Anxiety. 2009; 26 (5): 480-491.

  42. Kjelsberg FN, Ruud EA, Stavem K. Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med. 2005; 6 (4): 341-346.

  43. Zhang Y, Weed JG, Ren R, Tang X, Zhang W. Prevalence of obstructive sleep apnea in patients with posttraumatic stress disorder and its impact on adherence to continuous positive airway pressure therapy: a meta-analysis. Sleep Med. 2017; 36 (8): 125-132.

  44. Krakow B, Ulivarri VA, Moore BA, Mclver ND. Posttraumatic stress disorder and sleep-disordered breathing: a review of comorbidity research. Sleep Med Rev. 2015; 24 (6): 37-45.

  45. Krakow B, Melendrez D, Warner TD, Dorin R, Harper R, Hollifield M. To breathe, perchance to sleep: sleep-disordered breathing and chronic insomnia among trauma survivors. Sleep Breath. 2002; 6 (4): 189-202.

  46. El-Sohl AA, Vermont L, Homish GG, Kufel T. The effect of continuous positive airway pressure on post-traumatic stress disorder symptoms in veterans with post-traumatic stress disorder and obstructive sleep apnea: a prospective study. Sleep Med. 2017; 33 (5): 145-150.

  47. Orr JE, Smales C, Alexander T, Stepnowsky C, Pilar G, Malhotra A et al. Treatment of OSA with CPAP is associated with improvement in PTSD symptoms among veterans. J Clin Sleep Med. 2017; 13 (1): 57-63.

  48. Gupta MA, Simpson FC, Lyons DCA. The effect of treating obstructive sleep apnea with positive airway pressure on depression and other subjective symptoms: A systematic review and meta-analysis. Sleep Med Rev. 2016; 28: 55-68.




2020     |     www.medigraphic.com